Indaptus Therapeutics, Inc. (INDP) earnings
INDP earnings moved a median of +0.88% by the close. Quarterly and annual INDP reports and results, each read against the price at its own news timestamp. Back to the INDP overview →
21 measured INDP earnings events.
Where these INDP earnings landedvs 20 measured INDP earnings reactions
| Middle 50% of INDP earnings reactions | -3.22% to +3.92% |
|---|---|
| Median reaction (to close) | +0.88% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 INDP earnings events with a measured close landed between -3.22% and +3.92%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.94% | +3.60% | |
| Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update | Press release | — | — | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.92% | +3.92% | |
| Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +3.92% | +3.92% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -9.66% | |
| Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | — | -9.66% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -8.54% | -6.03% | |
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +6.97% | +5.86% | |
| Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +6.97% | +5.86% | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.66% | +7.79% | |
| Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.66% | +7.79% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.53% | -9.87% | |
| Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -3.53% | -9.87% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.85% | |
| Form 10-Q Indaptus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | +0.88% | |
| Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | +0.88% | |
| Form 10-Q Indaptus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.29% | |
| Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.00% | -2.29% | |
| Form 10-Q Indaptus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | +0.98% | |
| Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | — | +0.98% | |
| Form 10-K Indaptus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.49% | -0.50% |
Keep exploring
More INDP: analyst actions → · SEC filings → · INDP overview →